Valerie Rumple
Psychiatric/Mental Health · Fort Wayne, INNPI 1174706691
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,789 of the $7,948 with a category attached, or 85.4%. It is spread thinly across 24 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- Brainsway USA Inc$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$633
- Sunovion Pharmaceuticals Inc.$568
- Lundbeck LLC$544
- plus $3K from 18 others
What the payments were for
- Travel & lodging$1,02913%
- Food & beverage$6,78985%
- Education$1302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 37 | $1,387 |
| AbbVie | 73 | $1,058 |
| Brainsway USA Inc | 1 | $1,029 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $633 |
| Sunovion Pharmaceuticals Inc. | 28 | $568 |
| Lundbeck LLC | 74 | $544 |
| Axsome Therapeutics, Inc. | 12 | $509 |
| Alkermes, Inc. | 26 | $446 |
| Teva Pharmaceuticals USA, Inc. | 17 | $444 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $225 |
| Neurocrine Biosciences, Inc. | 11 | $181 |
| Johnson & Johnson | 10 | $174 |
| Indivior Inc. | 7 | $145 |
| Noven Therapeutics, LLC | 7 | $141 |
| Supernus Pharmaceuticals, Inc. | 5 | $94 |
| Corium, LLC | 7 | $92 |
| E.r. Squibb & Sons, L.L.C. | 2 | $62 |
| Biogen | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| Tris Pharma Inc | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Merck | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$463
- ABILIFY MAINTENA$368
- REXULTI$364
- VRAYLAR$249
- AUSTEDO$122
How this compares
$7,948 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 232 | $746,362 |
| AustedoDeutetrabenazine | 71 | $480,144 |
| Abilify MaintenaAripiprazole | 101 | $290,914 |
| VraylarCariprazine Hcl | 113 | $185,187 |
| Invega TrinzaPaliperidone Palmitate | 22 | $163,494 |
| RexultiBrexpiprazole | 108 | $143,621 |
| IngrezzaValbenazine Tosylate | 17 | $136,960 |
| Abilify AsimtufiiAripiprazole | 17 | $97,379 |
| TrintellixVortioxetine Hydrobromide | 120 | $77,001 |
| SpravatoEsketamine Hcl | 32 | $43,222 |
| CaplytaLumateperone Tosylate | 22 | $38,882 |
| LybalviOlanzapine/Samidorphan Malate | 26 | $37,449 |
| QuviviqDaridorexant Hcl | 66 | $37,361 |
| Austedo XrDeutetrabenazine | 11 | $36,727 |
| FanaptIloperidone | 12 | $25,574 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Spravato, Risperdal Consta | $174 | $968,149310 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti, Abilify Asimtufii | $1,387 | $531,913226 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $444 | $516,87182 claims |
| AbbVieVraylar | $1,058 | $185,187113 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $181 | $136,96017 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $225 | $77,001120 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $633 | $38,88222 claims |
| Alkermes, Inc.Lybalvi | $446 | $37,44926 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $18 | $37,36166 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $61 | $25,57412 claims |
| MerckBelsomra | $18 | $19,72535 claims |
| Axsome Therapeutics, Inc.Auvelity | $509 | $10,99011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Fort Wayne
- Sharon ClevengerFort Wayne$22K
- Teresa RobertsFort Wayne$13K
- Melodie GavinFort Wayne$9K
- Sherri AlbertsonFort Wayne$6K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.